HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun-Kang Chang Selected Research

Acute erythroleukemia

10/2017MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun-Kang Chang Research Topics

Disease

16Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 07/2007
8Neoplasms (Cancer)
08/2021 - 06/2011
4Iron Overload
01/2017 - 04/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2011 - 07/2007
3Multiple Myeloma
10/2013 - 06/2011
2Hematologic Neoplasms (Hematological Malignancy)
08/2021 - 02/2019
2Inflammation (Inflammations)
12/2018 - 08/2012
2Refractory Anemia with Excess of Blasts (RAEM)
10/2017 - 12/2014
2Abnormal Karyotype
12/2014 - 04/2012
2Disease Progression
06/2014 - 01/2014
2Hypoxia (Hypoxemia)
08/2012 - 04/2011
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2012 - 02/2011
1Chronic Hepatitis (Chronic Active Hepatitis)
12/2021
1Anemia
12/2018
1Chronic Disease (Chronic Diseases)
12/2018
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
12/2018
1Acute erythroleukemia
10/2017
1Acute Erythroblastic Leukemia (Erythroleukemia)
10/2017
1Leukemia
10/2017
1Testicular Neoplasms (Testicular Cancer)
01/2017
1Infections
12/2014
1monosomy Chromosome 7
12/2014
1Large Granular Lymphocytic Leukemia
06/2014
1Autoimmune Diseases (Autoimmune Disease)
06/2011
1Lymphoma (Lymphomas)
06/2011
1Neoplasm Metastasis (Metastasis)
06/2011
1Carcinoma (Carcinomatosis)
06/2011

Drug/Important Bio-Agent (IBA)

7IronIBA
12/2021 - 04/2011
5Biological ProductsIBA
01/2020 - 07/2007
5DecitabineFDA Link
01/2020 - 01/2017
3Messenger RNA (mRNA)IBA
01/2016 - 04/2012
2Ferritins (Ferritin)IBA
01/2021 - 08/2012
2ON 01910IBA
10/2017 - 12/2014
2AntigensIBA
01/2017 - 01/2014
2Inosine Triphosphate (ITP)IBA
08/2012 - 02/2011
2HepcidinsIBA
08/2012 - 04/2011
2Cytarabine (Cytosar-U)FDA LinkGeneric
06/2011 - 04/2009
1Galectins (Galectin)IBA
08/2021
1Biomarkers (Surrogate Marker)IBA
02/2019
1Insulin (Novolin)FDA Link
06/2018
1Insulin-Like PeptidesIBA
06/2018
1Hyaluronic Acid (Hyaluronan)IBA
01/2018
1MLN 8237IBA
10/2017
1Deferoxamine (Desferal)FDA LinkGeneric
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1MicroRNAs (MicroRNA)IBA
01/2016
1Jagged-1 ProteinIBA
12/2014
1LigandsIBA
12/2014
1interleukin-21 (interleukin 21)IBA
10/2013
1Interleukin-17 (Interleukin 17)IBA
10/2013
1Dietary IronIBA
04/2013
1Diphosphonates (Bisphosphonates)IBA
10/2012
1Rituximab (Mabthera)FDA Link
08/2012
1ErythropoietinFDA Link
08/2012
1Etoposide (VP 16)FDA LinkGeneric
06/2011
1Prednisone (Sone)FDA LinkGeneric
06/2011
1plerixaforFDA Link
06/2011
1HomoharringtonineIBA
04/2009
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2009

Therapy/Procedure

5Therapeutics
02/2019 - 08/2014
4Drug Therapy (Chemotherapy)
08/2021 - 06/2011
2Chelation Therapy (Therapy, Chelation)
12/2018 - 08/2014
1Immunotherapy
08/2021
1Hematopoietic Stem Cell Transplantation
06/2014
1Combination Drug Therapy (Combination Chemotherapy)
06/2014
1Blood Transfusion (Blood Transfusions)
04/2013
1Hematopoietic Stem Cell Mobilization
06/2011
1Induction Chemotherapy
04/2009